Amarin Corp. Plc (AMRN)
14.62
+0.16
(+1.07%)
USD |
NASDAQ |
Apr 01, 16:00
14.90
+0.28
(+1.95%)
Pre-Market: 09:17
Amarin Research and Development Expense (TTM) : 16.82M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Trinity Biotech Plc | 4.019M |
| Alkermes Plc | 318.36M |
| Jazz Pharmaceuticals Plc | 782.74M |
| Perrigo Co. Plc | 95.40M |
| Biodexa Pharmaceuticals Plc | 5.234M |